Balance Sheet
Cash Flow Statement
Amortization of Deferred ChargesAmortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesNet Cash FlowNet IncomeOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Growth Metrics
Income Statement
Others
Ratios

Core Scientific (CORZZ) Change in Receivables (2021 - 2025)

Historic Change in Receivables for Core Scientific (CORZZ) over the last 5 years, with Q1 2025 value amounting to -$6000.0.

  • Core Scientific's Change in Receivables fell 10566.04% to -$6000.0 in Q1 2025 from the same period last year, while for Mar 2025 it was -$771000.0, marking a year-over-year decrease of 18254.82%. This contributed to the annual value of -$659000.0 for FY2024, which is 18591.92% down from last year.
  • Latest data reveals that Core Scientific reported Change in Receivables of -$6000.0 as of Q1 2025, which was down 10566.04% from -$5.2 million recorded in Q4 2024.
  • In the past 5 years, Core Scientific's Change in Receivables ranged from a high of $9.4 million in Q2 2021 and a low of -$9.4 million during Q3 2021
  • For the 5-year period, Core Scientific's Change in Receivables averaged around $904647.1, with its median value being $780000.0 (2021).
  • Over the last 5 years, Core Scientific's Change in Receivables had its largest YoY gain of 69133.33% in 2024, and its largest YoY loss of 473425.93% in 2024.
  • Core Scientific's Change in Receivables (Quarter) stood at $780000.0 in 2021, then skyrocketed by 43.46% to $1.1 million in 2022, then plummeted by 109.65% to -$108000.0 in 2023, then plummeted by 4734.26% to -$5.2 million in 2024, then surged by 99.89% to -$6000.0 in 2025.
  • Its Change in Receivables was -$6000.0 in Q1 2025, compared to -$5.2 million in Q4 2024 and $887000.0 in Q3 2024.